These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Pleural effusions as markers of mortality and disease severity: a state-of-the-art review. DeBiasi E; Puchalski J Curr Opin Pulm Med; 2016 Jul; 22(4):386-91. PubMed ID: 27055075 [TBL] [Abstract][Full Text] [Related]
8. Clinical features and survival of lung cancer patients with pleural effusions. Porcel JM; Gasol A; Bielsa S; Civit C; Light RW; Salud A Respirology; 2015 May; 20(4):654-9. PubMed ID: 25706291 [TBL] [Abstract][Full Text] [Related]
9. Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion. Chung CL; Chen YC; Chang SC Chest; 2003 Apr; 123(4):1188-95. PubMed ID: 12684310 [TBL] [Abstract][Full Text] [Related]
10. Unilateral Pleural Effusions with More Than One Apparent Etiology. A Prospective Observational Study. Bintcliffe OJ; Hooper CE; Rider IJ; Finn RS; Morley AJ; Zahan-Evans N; Harvey JE; Skyrme-Jones AP; Maskell NA Ann Am Thorac Soc; 2016 Jul; 13(7):1050-6. PubMed ID: 27064965 [TBL] [Abstract][Full Text] [Related]
11. Thoracentesis in patients with hematologic malignancy: yield and safety. Bass J; White DA Chest; 2005 Jun; 127(6):2101-5. PubMed ID: 15947326 [TBL] [Abstract][Full Text] [Related]
12. Detection of Pleural Fluid Biochemistry Changes in Two Consecutive Thoracenteses for Differentiating Malignant from Benign Effusions. Bielsa S; García-Zamalloa A; Monteagudo P; González-Sans D; Ascanio D; Esquerda A; Taboada-Gómez J; Porcel JM Arch Bronconeumol (Engl Ed); 2018 Jun; 54(6):320-326. PubMed ID: 29496288 [TBL] [Abstract][Full Text] [Related]
13. Mortality Following Catheter Drainage Versus Thoracentesis in Cirrhotic Patients with Pleural Effusion. Hung TH; Tseng CW; Tsai CC; Hsieh YH; Tseng KC; Tsai CC Dig Dis Sci; 2017 Apr; 62(4):1080-1085. PubMed ID: 28130709 [TBL] [Abstract][Full Text] [Related]
17. Pleural effusion after ventricular assist device placement: prevalence and pleural fluid characteristics. Guha A; Munjampalli S; Bandi V; Loebe M; Noon G; Lunn W Chest; 2008 Aug; 134(2):382-386. PubMed ID: 18403665 [TBL] [Abstract][Full Text] [Related]
18. Prediction of Time to Next Therapeutic Thoracentesis and Identification of Risk Factors of Rapid Pleural Fluid Recurrence: A Prospective Observational Study. Fjaellegaard K; Petersen JK; Rasmussen DB; Clementsen PF; Laursen CB; Bhatnagar R; Bodtger U Respiration; 2023; 102(5):333-340. PubMed ID: 36843012 [TBL] [Abstract][Full Text] [Related]
19. Sensitivity of Initial Thoracentesis for Malignant Pleural Effusion Stratified by Tumor Type in Patients with Strong Evidence of Metastatic Disease. Grosu HB; Kazzaz F; Vakil E; Molina S; Ost D Respiration; 2018; 96(4):363-369. PubMed ID: 30016797 [TBL] [Abstract][Full Text] [Related]
20. Risk factors for pleural effusion recurrence in patients with malignancy. Grosu HB; Molina S; Casal R; Song J; Li L; Diaz-Mendoza J; Reddy C; Yarmus L; Schiavo D; Simoff M; Johnstun J; Raid AA; Feller-Kopman D; Lee H; Sahetya S; Foley F; Maldonado F; Tian X; Noor L; Miller R; Mudambi L; Saettele T; Vial-Rodriguez M; Eapen GA; Ost DE Respirology; 2019 Jan; 24(1):76-82. PubMed ID: 29966171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]